Use of polycyclic thiazole systems for the treatment of obesity
申请人:AventisPharma Deutschland GmbH
公开号:US06329407B1
公开(公告)日:2001-12-11
The invention relates to the use of polycyclic thiazole systems and their physiologically tolerated salts and physiologically functional derivatives for the treatment of obesity.
The treatment involves administration of a compound of formula I,
in which the radicals have the stated meanings, and of their physiologically tolerated salts and physiologically functional derivatives.